News & Views
News,
With over 15 years of hands-on experience in Diagnostic Imaging and Sales, Robyn will be solidifying our presence in the Western US. Robyn has an extensive background in Diagnostic Imaging…
Read more
News,
With more than 26 years of operations experience in the healthcare and life sciences field, Tony will be leading the sales organization as Vice President of Commercial Operations. Tony’s success…
Read more
Telix Pharmaceuticals announces that it has submitted a complete clinical briefing package to the US FDA for its first product…
Read more
Telix Pharmaceuticals Limited announces that it has submitted a Phase 3 IND application to the FDA for…
Read more
Telix Pharmaceuticals has released an update on the progress of its TLX101 product in the treatment of glioblastoma…
Read more
News,
Telix Pharmaceuticals announces University of Melbourne collaboration with Telix receives Cancer Australia research…
Read more
Telix Pharmaceuticals Limited and French company ATONCO S.A.S are pleased to announce they have entered into a Licence and Development Agreement that will enable ATONCO to investigate the use of Telix’s…
Read more
Telix Pharmaceuticals Limited is pleased to announce that Group CEO, Dr. Christian Behrenbruch, presented at Jefferies 2019 London Healthcare Conference….
Read more
Dr. Christian Behrenbruch, CEO of Telix Pharmaceuticals Limited will speak at Jefferies 2019 London Healthcare Conference. This year marks the 10th anniversary of now the largest healthcare-dedicated conference in Europe,…
Read more
Telix Pharmaceuticals Limited is pleased to release a Clinical Trial Program Update for Q3,…
Read more